10140faaae2dfe6f809aca0d05aa7424509b6a63
DLBCL_genes.md
| ... | ... | @@ -112,7 +112,7 @@ link-citations: true |
| 112 | 112 | |[RB1](RB1)|Tier 1 GE[@morinMutationalStructuralAnalysis2013]|[Morin et al](papers/morinMutationalStructuralAnalysis2013)|[@zhangGenomicLandscapeMantle2014]|| |
| 113 | 113 | |[RFX7](RFX7)|Tier 1 GE[@arthurGenomewideDiscoverySomatic2018]|[Arthur et al](papers/arthurGenomewideDiscoverySomatic2018)|[@grandeGenomewideDiscoverySomatic2019]|| |
| 114 | 114 | |[RHOA](RHOA)|Tier 1 GE[@zhangGeneticHeterogeneityDiffuse2013], FE[@ohayreInactivatingMutationsGNA132016]|[Zhang et al](papers/zhangGeneticHeterogeneityDiffuse2013)|[@richterRecurrentMutationID32012a]|| |
| 115 | -|[RRAGC](RRAGC)|Tier 1 GE[@okosunRecurrentMTORC1activatingRRAGC2016a]|[Okosun et al](papers/okosunRecurrentMTORC1activatingRRAGC2016a)||| |
|
| 115 | +|[RRAGC](RRAGC)|Tier 1 GE[@okosunRecurrentMTORC1activatingRRAGC2016a], FE[@ortega-molinaOncogenicRagGTPase2019b]|[Okosun et al](papers/okosunRecurrentMTORC1activatingRRAGC2016a)||| |
|
| 116 | 116 | |[S1PR2](S1PR2)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011]|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@muppidiLossSignalingGa132014b]|| |
| 117 | 117 | |[SETD1B](SETD1B)|Tier 1 GE[@albuquerqueEnhancingKnowledgeDiscovery2017a]|[Albuquerque et al](papers/albuquerqueEnhancingKnowledgeDiscovery2017a)||| |
| 118 | 118 | |[SF3B1](SF3B1)|Tier 1 GE[@reddyGeneticFunctionalDrivers2017]|[Reddy et al](papers/reddyGeneticFunctionalDrivers2017)|[@loveGeneticLandscapeMutations2012]|| |
morinlab.bib
| ... | ... | @@ -1,3 +1,23 @@ |
| 1 | +@article{ortega-molinaOncogenicRagGTPase2019b, |
|
| 2 | + title = {Oncogenic {{Rag GTPase}} Signaling Enhances {{B}} Cell Activation and Drives Follicular Lymphoma Sensitive to Pharmacological Inhibition of {{mTOR}}}, |
|
| 3 | + author = {Ortega-Molina, Ana and Deleyto-Seldas, Nerea and Carreras, Joaquim and Sanz, Alba and Lebrero-Fernández, Cristina and Menéndez, Camino and Vandenberg, Andrew and Fernández-Ruiz, Beatriz and Marín-Arraiza, Leyre and family=Calle Arregui, given=Celia, prefix=de la, useprefix=true and Belén Plata-Gómez, Ana and Caleiras, Eduardo and family=Martino, given=Alba, prefix=de, useprefix=true and Martínez-Martín, Nuria and Troulé, Kevin and Piñeiro-Yáñez, Elena and Nakamura, Naoya and Araf, Shamzah and Victora, Gabriel D. and Okosun, Jessica and Fitzgibbon, Jude and Efeyan, Alejo}, |
|
| 4 | + date = {2019-08}, |
|
| 5 | + journaltitle = {Nature Metabolism}, |
|
| 6 | + shortjournal = {Nat Metab}, |
|
| 7 | + volume = {1}, |
|
| 8 | + number = {8}, |
|
| 9 | + eprint = {31579886}, |
|
| 10 | + eprinttype = {pmid}, |
|
| 11 | + pages = {775--789}, |
|
| 12 | + issn = {2522-5812}, |
|
| 13 | + doi = {10.1038/s42255-019-0098-8}, |
|
| 14 | + abstract = {The humoral immune response demands that B cells undergo a sudden anabolic shift and high cellular nutrient levels which are required to sustain the subsequent proliferative burst. Follicular lymphoma (FL) originates from B cells that have participated in the humoral response, and 15\% of FL samples harbor point, activating mutations in RRAGC, an essential activator of mTORC1 downstream of the sensing of cellular nutrients. The impact of recurrent RRAGC mutations in B cell function and lymphoma is unexplored. RRAGC mutations, targeted to the endogenous locus in mice, confer a partial insensitivity to nutrient deprivation, but strongly exacerbate B cell responses and accelerate lymphomagenesis, while creating a selective vulnerability to pharmacological inhibition of mTORC1. This moderate increase in nutrient signaling synergizes with paracrine cues from the supportive T cell microenvironment that activates B cells via the PI3K-Akt-mTORC1 axis. Hence, Rragc mutations sustain induced germinal centers and murine and human FL in the presence of decreased T cell help. Our results support a model in which activating mutations in the nutrient signaling pathway foster lymphomagenesis by corrupting a nutrient-dependent control over paracrine signals from the T cell microenvironment.}, |
|
| 15 | + langid = {english}, |
|
| 16 | + pmcid = {PMC6774795}, |
|
| 17 | + keywords = {Animals,apoptosis,B cell lymphoma,B lymphocytes,cell growth,germinal center,GTP Phosphohydrolases,Humans,Lymphocyte Activation,Lymphoma Follicular,Mice,Mice Transgenic,mTOR,nutrient signaling,rapamycin,RRAGC,Signal Transduction,T follicular helper,TOR Serine-Threonine Kinases}, |
|
| 18 | + file = {/Users/rmorin/Zotero/storage/26JEZPT2/Ortega-Molina et al. - 2019 - Oncogenic Rag GTPase signaling enhances B cell act.pdf} |
|
| 19 | +} |
|
| 20 | + |
|
| 1 | 21 | @article{thomasMutationalAnalysisIkappaBalpha2004, |
| 2 | 22 | title = {Mutational Analysis of the {{IkappaBalpha}} Gene in Activated {{B}} Cell-like Diffuse Large {{B-cell}} Lymphoma}, |
| 3 | 23 | author = {Thomas, Roman K. and Wickenhauser, Claudia and Tawadros, Samir and Diehl, Volker and Küppers, Ralf and Wolf, Jürgen and Schmitz, Roland}, |